吡哆醛/吡哆醇*6磷酸酶（PDXP）

EJ/GlyRS

试剂盒名称:吡哆醛/吡哆醇*6磷酸酶(PDXP)ELISA试剂盒

英文名：Human anti-EJ-antibody，EJ/GlyRS

品牌:BIOFINE
种属:大鼠ELISA试剂盒
检测波长:450nm
所需样本体积: 50-100ul
适用范围:仅供科研
保存及有效期:2-8℃，六个月，-20℃一年
检测目的:用于测定血清，血浆及相关液体吡哆醛/吡哆醇*6磷酸酶(PDXP)含量。适合检测包括血清、血浆、尿液、胸腹水、灌洗液、脑脊液、细胞培养上清、组织匀浆等标本。 

注意事项：1. 当混合蛋白溶液时应尽量轻缓，避免起泡。2. 洗涤过程非常重要，不充分的洗涤易造成假阳性。3. 一次加样时间控制在5分钟内，如标本数量多，*使用排枪加样。4. 请每次测定的同时做标准曲线，做复孔。5. 如标本中待测物质含量过高，请先稀释后再测定，计算时请zui后乘以稀释倍数。6. 在配制标准品、检测溶液工作液时，请以相应的稀释液配制，不能混淆。7. 底物请避光保存。8. 不要用其它生产厂家的试剂替换试剂盒中的试剂。

吡哆醛/吡哆醇*6磷酸酶(PDXP)contains the standard concentration of analyte will be prepared. Unknowns that generate a signal that is stronger than the known sample are "positive." Those that generate weaker signal are "negative." Doctor Dennis E Bidwell and Alister Voller created the test. History Before the development of the ELISA, the only option for conducting an immunoassay was radioimmunoassay, a technique using radioactively-labeled antigens or antibodies. In radioimmunoassay, the radioactivity provides the signal, which indicates whether a specific antigen or antibody is present in the sample. Radioimmunoassay was first described in a paper by Rosalyn Sussman Yalow and Solomon Berson published in 1960.[5] Because radioactivity poses a potential health threat, a safer alternative was sought. A suitable alternative to radioimmunoassay would substitute a non-radioactive signal in place of the radioactive signal. When enzymes (such as peroxidase) react with appropriate substrates (such as ABTS or 3,3’,5,5’-Tetramethylbenzidine), a change in color occurs, which is used as a signal. However, the signal has to be associated with the presence of antibody or antigen, which is why the enzyme has to be linked to an appropriate antibody. This linking process was independently developed by Stratis Avrameas and G.B. Pierce.[6] Since it is necessary to remove any unbound antibody or antigen by washing, the antibody or antigen has to be fixed to the surface of the container; i.e., the immunosorbent has to be prepared. A technique to accomplish this was published by Wide and Jerker Porath in 1966.[7] In 1971, Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in The Netherlands independently published papers that synthesized this knowledge into methods to perform EIA/ELISA.[8][9]

吡哆醛/吡哆醇*6磷酸酶(PDXP)

细胞间粘附分子2(ICAM-2/CD102)

骨保护素(OPG)

心肌特异性肌钙蛋白T(cTnT)

降钙素基因相关肽(CGRP)

5脂加氧酶(5-LO/LOX)

儿茶酚胺(CA)

肽聚糖(PG)

毒蕈碱型乙酰*受体(M-AChR)

酸性磷酸酶(ACP)

低密度脂蛋白免疫复合物(LDL-IC)

双氢睾酮(DHT)

蛋白激酶A(PKA)